All Pathways
Cardiothoracic SurgeryEmergency

Massive Hemoptysis Management (CCI/EMCrit 2025)

Massive Hemoptysis Management (CCI/EMCrit 2025): Massive Hemoptysis → ⚠️ AIRWAY IS PRIORITY #1 → Immediate Actions → Intubation Needed? → Airway Managem...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Massive Hemoptysis

    >100-200 mL/24h OR any amount causing hemodynamic/respiratory compromise

    1. Warning

      ⚠️ AIRWAY IS PRIORITY #1

      Death is from asphyxiation, not exsanguination

      • Mortality >50% without intervention
      • 150 mL fills anatomic dead space
      • Patient drowns in their own blood
      1. Action

        Immediate Actions

        Stabilize and protect airway

        • BLEEDING LUNG DOWN (lateral decubitus)
        • High-flow O2, prepare for intubation
        • Large bore IV access, type & crossmatch
        • Hold anticoagulants/antiplatelets
        • Tranexamic acid 1g IV (consider)
        • Call: Pulmonology, IR, Thoracic Surgery
        1. Decision

          Intubation Needed?

          Respiratory failure, hemodynamic instability, or massive ongoing bleeding

          1. Action

            Airway Management

            Intubate with largest ETT possible

            • ≥8.0 ETT to allow bronchoscopy
            • Consider mainstem intubation of non-bleeding lung
            • Double-lumen tube if experienced (lung isolation)
            • Bronchial blocker alternative
            • Suction frequently
            1. Action

              Localize Bleeding Source

              Identify side and cause

              • CXR: may show infiltrate on bleeding side
              • CT Angiography (if stable): identifies source, anatomy
              • Bronchoscopy: localizes to lobe/segment
              • Common causes:
              • • Bronchiectasis, TB, aspergilloma
              • • Lung cancer, pulmonary artery erosion
              • • AVM, trauma, iatrogenic
              1. Action

                Bronchoscopy

                Diagnostic and potentially therapeutic

                • Flexible or rigid (rigid better for massive)
                • Localize bleeding segment
                • Therapeutic options:
                • • Cold saline lavage
                • • Topical epinephrine (1:20,000)
                • • Endobronchial tamponade (balloon, blocker)
                • • Laser/electrocautery if visible lesion
                1. Decision

                  Definitive Therapy Selection

                  Based on stability and anatomy

                  1. Action

                    Bronchial Artery Embolization (BAE)

                    First-line definitive therapy (Class I)

                    • ~90% of massive hemoptysis from bronchial arteries
                    • Initial success rate ~80%
                    • Super-selective catheterization recommended
                    • Embolic agents (CCI 2025):
                    • • PVA particles (most common)
                    • • Gelfoam (temporary)
                    • • NBCA/glue (massive/refractory cases)
                    • • Coils (larger vessels)
                    • ⚠️ Identify spinal artery before embolizing
                    1. Action

                      Post-Procedure Management

                      Monitor and treat underlying cause

                      • ICU monitoring 24-48h
                      • Treat underlying disease (TB, infection)
                      • Recurrence rate 10-30% after BAE
                      • Repeat BAE possible if anatomy favorable
                      • Surgical consultation if recurrent
                      1. Outcome

                        Bleeding Controlled

                        Continue disease-specific therapy

                    2. Action

                      Surgical Resection

                      When BAE fails or not feasible

                      • INDICATIONS:
                      • • BAE failure or recurrence
                      • • Rasmussen aneurysm (PA erosion)
                      • • Lung cancer with hemorrhage
                      • • Aspergilloma (definitive cure)
                      • • Trauma with vascular injury
                      • Lobectomy or pneumonectomy
                      • High mortality in emergency setting (20-40%)

Guideline Source

CCI 2025 Consensus on Bronchial Artery Embolization for Hemoptysis

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Definition of 'massive' varies (100-600+ mL/24h in literature)
  • BAE success rates vary by etiology and center experience
  • Requires interventional radiology and thoracic surgery availability
  • Spinal cord ischemia risk with BAE (1-6%)
  • Recurrence rates 10-30% after BAE

Applicable Regions

USEU
Version 1Next review: 2027-01-11

Frequently Asked Questions

What is the Massive Hemoptysis Management (CCI/EMCrit 2025)?

The Massive Hemoptysis Management (CCI/EMCrit 2025) is a emergency clinical algorithm for Cardiothoracic Surgery. It provides a structured decision tree to guide clinical decision-making, based on CCI 2025 Consensus on Bronchial Artery Embolization for Hemoptysis.

What guideline is the Massive Hemoptysis Management (CCI/EMCrit 2025) based on?

This algorithm is based on CCI 2025 Consensus on Bronchial Artery Embolization for Hemoptysis (DOI: CCI-2025-BAE-Consensus).

What are the limitations of the Massive Hemoptysis Management (CCI/EMCrit 2025)?

Known limitations include: Definition of 'massive' varies (100-600+ mL/24h in literature); BAE success rates vary by etiology and center experience; Requires interventional radiology and thoracic surgery availability; Spinal cord ischemia risk with BAE (1-6%); Recurrence rates 10-30% after BAE. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Massive Hemoptysis Management (CCI/EMCrit 2025) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free